← SynDRA
LANSOPRAZOLE
SynDRA canonical compound SYN0000381 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ATP4A |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
| Indication | heartburn |
|---|
| Disease area | gastroenterology |
|---|
All known targets
- ATP4A
- ATP4B
- CYP2C19
- ABCG2
- CYP2D6
- CYP3A4
- CYP3A5
- DDAH1
- ENGASE
- FASN
- IDO1
- IDO2
Mechanisms of action (all sources)
- ATPase inhibitor
- ATP4A INHIBITOR
- Potassium-transporting ATPase inhibitor
- ATP4B INHIBITOR
Drug classes
- Proton Pump Inhibitors
- Proton Pump Inhibitor
- Anti-Ulcer Agents
- Enzyme Inhibitors
- Gastrointestinal Agents
ATC classes
- A02B · DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Cross-references
Synonyms
- prevacid
- A-65006
- AG-1749
- Lansoprazol
- Agopton
- Lansox
- Lanzoprazole
- Lanzor
- Limpidex
- Ogast
- Ogastoro
- Prevonco
- Takepron
- NSC-758638
- Lansoprazole component of prevpac
- Opiren
- Prevacid
- Prevacid 24 hr
- Prevacid delayed release
- Prevacid iv
- Prevacid solutab
- Zoton
- lansoprazole (ep monograph)
- lanzoprazole
- lansoprazole (usp-rs)
- lansoprazole (usp monograph)
- PREVPAC COMPONENT LANSOPRAZOLE
- A 65006
- PrevOnco
- AG 1749
- (+-)-lansoprazole
- 0K5C5T2QPG
- NSC 758638
- Prevacid SoluTab
- Lanzopral
- Lansoprazolum
- Prevacid Iv
- CHEBI:6375
Reported adverse events
- Headache
- Nausea
- Constipation
- Fracture
- Stevens-Johnson syndrome
- Hypersensitivity
- Agranulocytosis
- Arthralgia
- Malaise
- Myalgia
- Rash
- Stomatitis
Look up LANSOPRAZOLE in the interactive SynDRA portal →